Scientists determine why some patients don't respond well to wet macular degeneration treatment, show how new experimental drug can bridge gap.

MLA

“Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap.” Health & Medicine Week, Nov. 2024, p. 2375. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180891927&authtype=sso&custid=ns315887.

APA

Scientists determine why some patients don’t respond well to wet macular degeneration treatment, show how new experimental drug can bridge gap. (2024). Health & Medicine Week, 2375.

Chicago

“Scientists Determine Why Some Patients Don’t Respond Well to Wet Macular Degeneration Treatment, Show How New Experimental Drug Can Bridge Gap.” 2024. Health & Medicine Week, November, 2375. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180891927&authtype=sso&custid=ns315887.